Psychedelic research and sexuality: opportunities and pitfalls.
The Journal of Sexual Medicine February 1, 2026 Hendrikus Knegtering, Thalia Herder, Nynke Boonstra et al.
Psychedelic-assisted therapy (PAT) is increasingly investigated as a treatment for depression, post-traumatic stress disorder (PTSD), and substance use disorder. In the United States (US) and European Union, esketamine has been approved for the treatment of depression, while psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) have received Breakthrough Therapy Designation in the US for...
DOI: 10.1093/jsxmed/qdag025 (opens in new tab)
Psychedelic-assisted therapy
Sexual function
Sexual dysfunction
Psychedelics